Biomedical Tissue Services, Ltd.

Form 483 issued September 30, 2003 · Fort Lee, New Jersey

Inspection
Sep 19 – Sep 30, 2003
Investigator
Helen B. Ricalde
Observations
2
Pages
83
FEI number
3003652678

In short: On September 30, 2003, FDA issued a Form 483 with 2 observations to Biomedical Tissue Services, Ltd. in Fort Lee, New Jersey (FEI 3003652678) after an inspection that ran Sep 19 – Sep 30, 2003. The investigator was Helen B. Ricalde. Most observations concern hCT/P; the most-cited regulation is 21 CFR 1271.200 (equipment).

At a glance

2 of 2 observations on this 483 concern hct/p.

HCT/P2

Most cited: 21 CFR 1271.200 (1×) · 1271.270 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to validate and follow written procedures for prevention…

  2. 02

    Records fail to include documentation of destruction or other…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Biomedical Tissue Services, Ltd.?

FDA listed 2 observations on this Form 483, mostly about hCT/P. The most-cited regulation is 21 CFR 1271.200 (equipment). The opening words of each observation are shown on this page.

Who inspected Biomedical Tissue Services, Ltd.?

Helen B. Ricalde is named on this Form 483, for the inspection of Sep 19 – Sep 30, 2003. Each investigator has a profile showing what they cite most.

When was Biomedical Tissue Services, Ltd. inspected by FDA?

The inspection ran Sep 19 – Sep 30, 2003, and the Form 483 is dated September 30, 2003.

How do I get the full Form 483 for Biomedical Tissue Services, Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free